Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Malignant Melanoma of Skin AJCC V6”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02595866
What this trial is testing

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Who this might be right for
AIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more
National Cancer Institute (NCI) 58
Testing effectiveness (Phase 2)Study completedNCT00003646
What this trial is testing

Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Stage IV MelanomaStage III MelanomaRecurrent Melanoma
Vical 78
Testing effectiveness (Phase 2)Study completedNCT00003346
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Memorial Sloan Kettering Cancer Center 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT01989585
What this trial is testing

Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant Melanoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Malignant Solid Neoplasm+2 more
National Cancer Institute (NCI) 75
Testing effectiveness (Phase 2)Study completedNCT00004022
What this trial is testing

Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Looking for participantsNCT04598009
What this trial is testing

Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
University of California, San Francisco 25
Large-scale testing (Phase 3)Active Not RecruitingNCT02339571
What this trial is testing

A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma

Who this might be right for
Stage III Cutaneous Melanoma AJCC v7Stage IV Cutaneous Melanoma AJCC v6 and v7
National Cancer Institute (NCI) 600
Testing effectiveness (Phase 2)Study completedNCT01258855
What this trial is testing

Aldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Metastatic MelanomaRecurrent MelanomaStage III Cutaneous Melanoma AJCC v7+4 more
National Cancer Institute (NCI) 84
Testing effectiveness (Phase 2)UnknownNCT05370807
What this trial is testing

A Clinical Trial of Regorafenib in Patients With Pretreated Advanced Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Universitair Ziekenhuis Brussel 48
Testing effectiveness (Phase 2)WithdrawnNCT01764009
What this trial is testing

Safety and Efficacy of Intramuscular Electrotransfer of Plasmid AMEP in Patients Suffering From Advanced or Metastatic Melanoma

Who this might be right for
Melanoma
Valerio Therapeutics
Not applicableStudy completedNCT01986712
What this trial is testing

Compare Quality of Life and Compliance in Patients Receiving High-dose Interferon Versus Pegylated Interferon in Patients With Surgically Resected Melanoma

Who this might be right for
Melanoma
St. Luke's Hospital and Health Network, Pennsylvania 50
Testing effectiveness (Phase 2)Study completedNCT00089219
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
University of Virginia 39
Testing effectiveness (Phase 2)Looking for participantsNCT05655312
What this trial is testing

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

Who this might be right for
Recurrent Melanoma (Skin)Metastatic MelanomaMelanoma Stage IV+1 more
Perspective Therapeutics 300
Early research (Phase 1)Ended earlyNCT00667901
What this trial is testing

Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery

Who this might be right for
Melanoma (Skin)
University of Medicine and Dentistry of New Jersey 15
Not applicableNo Longer AvailableNCT04544202
What this trial is testing

Compassionate Use Program BRAF Mutation-positive Patients in the Adjuvant Treatment of Melanoma After Surgical Resection

Who this might be right for
MelanomaAdjuvant
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00101166
What this trial is testing

Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in Melanoma

Who this might be right for
Melanoma (Skin)
H. Lee Moffitt Cancer Center and Research Institute 43
Testing effectiveness (Phase 2)WithdrawnNCT04007588
What this trial is testing

A Phase II Trial of Neoadjuvant Treatment With PD-1 Inhibition (Nivolumab) With or Without IDO Inhibition (BMS-986205) and With or Without CTLA-4 Inhibition (Ipilimumab) in Resectable Stage III or IV Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Dana-Farber Cancer Institute
Not applicableActive Not RecruitingNCT05736523
What this trial is testing

Improving Early Detection of Melanoma Recurrence With Circulating Tumor DNA (ctDNA)

Who this might be right for
Melanoma
University of Utah 28
Early research (Phase 1)Study completedNCT00790010
What this trial is testing

Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV Melanoma

Who this might be right for
Melanoma
Dana-Farber Cancer Institute 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT04462406
What this trial is testing

Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial

Who this might be right for
Advanced MelanomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+8 more
ECOG-ACRIN Cancer Research Group 150
Next Page